Clinical Trial Detail

NCT ID NCT02511795
Title AZD1775 Combined With Olaparib in Patients With Refractory Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors AstraZeneca
Indications

Advanced Solid Tumor

Therapies

Adavosertib

Olaparib

Age Groups: adult

No variant requirements are available.